PubRank

Zoledronic acid for neonatal subcutaneous fat necrosis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28469850)

Published in Clin Case Rep on March 14, 2017

Authors

Jeremy A Di Bari1, Jennifer A Nead2, Scott J Schurman3

Author Affiliations

1: Resident, Family MedicineSt. Joseph's Hospital Health Center301 Prospect AveSyracuseNew York13203USA.
2: Division of Hospital MedicineDepartment of Pediatrics5511 Upstate University HospitalSUNY Upstate Medical University750 East Adams StreetSyracuseNew York13210USA.
3: Division of NephrologyDepartment of Pediatrics5511 Upstate University HospitalSUNY Upstate Medical University750 East Adams StreetSyracuseNew York13210USA.

Articles cited by this ↗

Pamidronate: Treatment for severe hypercalcemia in neonatal subcutaneous fat necrosis. Horm Res (2006) 2.78

Subcutaneous fat necrosis of the newborn: a review of 11 cases. Pediatr Dermatol (2000) 1.70

Complications of subcutaneous fat necrosis of the newborn: a case report and review of the literature. Pediatr Dermatol (2003) 1.39

Effectiveness of pamidronate in severe neonatal hypercalcemia caused by subcutaneous fat necrosis: a case report. Eur J Pediatr (2008) 1.20

Acute phase response and mineral status following low dose intravenous zoledronic acid in children. Bone (2007) 1.14